Roche Beats Rivals To Japan Tumor-Agnostic Market With World-First Rozlytrek Nod

 
• By Ian Haydock
Cancer - DNA - test tube
Japan Nod For Rozlytrek In Specific Tumor Type • Source: Shutterstock

More from Japan

More from Focus On Asia